Medical management of small preterm infants with symptomatic patent ductus arteriosus

Insights

Medical management of patent ductus arteriosus in preterm infants achieved 71% survival. This approach, without surgical or pharmacologic intervention, led to pulmonary complications due to mechanical ventilation.

Area of Science:

  • Neonatalogy
  • Pediatric Cardiology
  • Critical Care Medicine

Background:

  • Patent ductus arteriosus (PDA) is a common condition in preterm infants.
  • PDA can lead to severe complications like pulmonary edema and congestive heart failure.
  • Optimal management strategies for PDA in very low birth weight infants remain debated.

Purpose of the Study:

  • To evaluate the outcomes of conservative medical management for PDA in infants with birth weights ≤1,500 gm.
  • To assess survival rates and complications associated with non-interventional PDA treatment.
  • To provide data for designing future clinical trials on PDA management.

Main Methods:

  • Retrospective analysis of 44 infants with PDA and complications managed medically.
  • Infants received conservative treatment until spontaneous ductal closure.
  • Mechanical ventilation was used to manage pulmonary edema.

Main Results:

  • Overall survival rate was 71% (27 out of 38 infants).
  • No deaths occurred in infants weighing >1,250 gm.
  • Pulmonary complications were frequent, linked to mechanical ventilation use.

Conclusions:

  • Conservative medical management of symptomatic PDA in small preterm infants is associated with significant survival.
  • Extensive mechanical ventilation is often required, leading to pulmonary complications.
  • These findings support the design of clinical trials comparing different PDA management strategies.

Related Concept Videos

Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...